Abstract | Single nucleotide polymorphisms (SNPs) that cluster in the first intron of fat mass and obesity associated (FTO) gene are associated obesity traits in genome-wide association studies. The minor allele increases BMI by 0.39 kg/m 2 (or 1,130 g in body weight) and risk of obesity by 1.20-fold. This association has been confirmed across age groups and populations of diverse ancestry; the largest effect is seen in young adulthood. The effect of FTO SNPs on obesity traits in populations of African and Asian ancestry is similar or somewhat smaller than in European ancestry populations. However, the BMI-increasing allele in FTO is substantially less prevalent in populations with non-European ancestry. FTO SNPs do not influence physical activity levels; yet, in physically active individuals, FTO's effect on obesity susceptibility is attenuated by approximately 30%. Evidence from epidemiological and functional studies suggests that FTO confers an increased risk of obesity by subtly changing food intake and preference. Moreover, emerging data suggest a role for FTO in nutrient sensing, regulation of mRNA translation and general growth. In this Review, we discuss the genetic epidemiology of FTO and discuss how its complex biology might link to the regulation of body weight.
Introduction
In the general population, an estimated 40-70% of the vari ation in obesity susceptibility arises from inter individual genetic differences. 1, 2 Despite this substantial genetic contri bution, the identification of genetic variants asso ciated with obesity traits has been limited by our poor understanding of genome architecture and of the bio logical pathways implicated in obesity, as well as by small, insufficiently powered studies. 3 However, the develop ment of genomewide association studies (GWAS)-a hypothesis free approach made possible by advances in high throughput genotyping technology-has dramatically increased the speed of gene discovery. GWAS have identi fied approximately 2,000 genetic loci with robust associ ations for more than 300 common traits and diseases, 4, 5 including at least 75 obesity susceptibility loci. 6, 7 The FTO (fat mass and obesity associated) gene was the first obesity susceptibility gene identified by GWAS. 8, 9 This locus has the largest effect on BMI and obesity risk and is most widely replicated with a variety of obesity traits throughout the life course and across diverse ancestries. 7 In this Review we discuss the discovery of FTO as an obesity gene and the insights gained through epidemiological and functional followup studies to elucidate the biological pathways that underlie the association between FTO and obesity.
Genetic epidemiology of FTO
FTO-the first obesity susceptibility gene In 2007, two studies reported the discovery of FTO as the first GWASidentified obesity susceptibility gene. 8, 9 FTO was first discovered in a GWAS of type 2 diabetes melli tus (T2DM) in Europe that compared 1,924 patients with 2,938 healthy individuals. 8 A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the gene showed robust association with T2DM risk (P = 5 × 10 -8 ), which was convincingly replicated in an independent casecontrol study (P = 9 × 10 -6 ). 8 However, after adjusting for BMI in the replication samples, the association with T2DM was abolished (P = 0.44), suggesting that the association of FTO with T2DM was mediated through effects on BMI. Followup analyses in 38,759 individuals confirmed that FTO is associated with BMI and obesity risk. 8 8 weeks after the initial report, the first GWAS for BMI demonstrated the most significant associations for SNPs in the first intron of FTO (P = 9 × 10 -7 ) in 4,741 individuals from Sardinia. These results were subsequently replicated in 2,335 European and Hispanic Americans (P = 10 -3 ). 9 A third study identified the same FTO locus when testing for population strati fication in case-control obesity data. 10 These three studies firmly established FTO as the first gene with common poly morphisms that affect obesity susceptibili ty in the general population.
The FTO locus The first two GWAS that reported FTO as an obesity sus ceptibility gene each identified different SNPs in the gene's first intron that most significantly associated with BMI (rs9939609, 8 rs9930506; 9 Figure 1 ). Subsequent GWAS for obesityrelated traits in populations with European ancestry all confirmed FTO as an obesity susceptibility locus, but each identified different FTO SNPs that showed the most significant association. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] For example, data from 247,796 individuals of European ancestry, found SNP rs1558902 is most significantly associated with BMI (P <10 -60 , Figure 1 ). 16 However, multi ple neighbouring SNPs (Figure 1a ) also show highly significant associations with BMI (P <10 -50 ). Linkage disequilibrium (LD) is a measure of associ ation between two alleles (Box 1). All GWASidentified FTO SNPs belong to the same highly correlated cluster, with an LD of r 2 >0.80, and consequently are associated with BMI at similar signifi cance levels (Figure 1a) , as well as with other obesityrelated traits. In populations with European ancestry, the SNP cluster that includes all GWAS identified FTO SNPs covers ~46,000 base pairs in the first intron of FTO that likely include the functional variant that explains the risk and associated phenotype, known as the causal variant. The cluster of BMIassociated FTO SNPs in East Asian populations is very similar to that of European ancestry populations (Figure 1b) . Three large scale GWAS in Korean
23
, Chinese 24 and Japanese 25 popu lations each identified different FTO SNPs (rs9939609, rs17817449, rs12149832, respectively) as the most signifi cantly associ ated with BMI, all of which are highly cor related (LD r 2 >0.90) in both East Asian and European populations (Figure 1b) . However, in populations of African ancestry, the correlation between SNPs in the first intron of FTO is substantially weaker than in those with European or East Asian ancestry (Figure 1b) . This difference in LD allows refinement of the chromo somal region in which the causal variant(s) might be located. For example, a largescale GWAS in a group with African ancestry combined data from 45,849 individuals and identified rs17817964 as the most significantly BMI associated FTO SNP. 26 In populations of European and East Asian ancestry, rs17817964 is part of the same large cluster in FTO intron 1, whereas in African ancestry populations it represents a cluster of fewer SNPs across a smaller region, thus narrowing the locus that harbours the causal FTO variant (Figure 1b) . In a targeted fine mapping by the Population Architecture using Genomics and Epidemiology (PAGE) study, 27 the genotypes of 3,756 SNPs across a 646 kb region at chromosomal loca tion 16q12.2, encompassing FTO and the neighbouring RPGRIP1L, were tested in >20,000 African Americans. In this study, rs56137030 is most significantly associ ated with BMI. 27 In individuals of Europeans ancestry, this SNP represents a cluster (LD r 2 for European ances try >0.50) of 103 (out of the 3,756 total) SNPs, whereas in African Americans this cluster includes only 29 SNPs (due to weaker LD between SNPs). 27 Six of the 29 SNPs are found within intronic regulatory elements, two of which are predicted to have allelespecific binding affinities for different transcription factors, including cutlike homeobox 1, which might influence the transcription al re gulation of FTO. 28, 29 Taken together, the BMIassociated FTO region, ini tially identified in European populations, has been refined using the weaker correlation between SNPs in popula tions with African ancestry. These insights will help focus studies to pinpoint the causal variants.
Effect and variance across populations
At least 75 obesity susceptibility loci have been identi fied in addition to FTO using largescale GWAS. 7 However, among individuals of European ancestry, the FTO locus has the greatest effect on obesity, is the most common, and has the largest explained variance. Specifically, each additional minor risk allele is associated with a 0.39 kg/m 2 higher BMI (equivalent to 1.13 kg for a person who is 1.70 m tall) and a 1.2fold increase in obesity risk (Table 1) . 16 Approximately 43% of the Europeanancestry population carries one risk allele and 20% carry two, with small variations in genotype frequencies within these populations ( Figure 2 ). Although the FTO locus explains the interindividual variation in BMI better than any other BMIassociated loci identified to date, its contribution is low at only 0.34%. 16 Consequently, the ability to predict a person's obesity risk based on FTO genotype is poor-only slightly better than tossing a coin. 30 Soon after the discovery of FTO in European popula tions, other studies investigated its effects in groups with nonEuropean ancestry, supporting the association of FTO as a general obesity susceptibility locus. The most consistent replications have been observed for indivi duals with Asian ancestry. Three largescale GWAS in East Asian populations identified FTO SNPs as signifi cantly associated with BMI. [23] [24] [25] Furthermore, targeted studies of specific population groups consistently con firmed the association of FTO with obesityrelated traits in Chinese, [31] [32] [33] [34] [35] [36] [37] [38] [39] Japanese, [40] [41] [42] [43] [44] Koreans, 45, 46 Vietnamese, 47 Filipino, 48 Malay 31 and Indian Asian populations. [49] [50] [51] [52] [53] [54] [55] [56] [57] In a metaanalysis that combined data of 96,551 individuals of Asian ancestry, each additional minor allele increases the risk of obesity (using Asian BMI cutoff values) by 1.25 fold, which is similar to the effect seen in European popu lations. 58 BMI increases by 0.26 kg/m 2 (equivalent to 750 g for a person who is 1.70 m tall) for each additional minor allele, 58 which is substantially less than in those with European ancestry and might reflect the fact that BMI represents a different adiposity phenotype in Asian popu lations compared with Europeans. Effect sizes of East and South Asian populations were similar, but the minor allele frequency was lower in East Asians (Chinese Hans and South Koreans, 12-14%; Japanese and Filipinos, 18-20%) than in South Asians (30-33%), which in turn are both lower than in European individuals (42%; Table 1 ). As a Key points ■ A cluster of single nucleotide polymorphisms (SNPs) in intron 1 of fat mass and obesity associated (FTO) gene was the first obesity susceptibility locus identified by a genome-wide association study (GWAS) ■ FTO is an RNA demethylase that links amino acid availability and mTORC1 signalling to regulate growth and mRNA translation ■ Of all GWAS-identified obesity susceptibility loci, the FTO locus has the largest effect; SNPs in the FTO locus are associated with obesity traits, throughout life and across diverse ancestries ■ SNPs in FTO are also associated with non-adiposity traits, such as cardiometabolic traits, type 2 diabetes mellitus and osteoarthritis; most of these associations are mediated through FTO's effect on BMI ■ Evidence from epidemiological and functional studies suggests that FTO confers an increased risk of obesity through subtle changes in food intake and preference consequence of the smaller effect size and lower minor allele frequency (Figure 2 ), FTO SNPs in Asian popula tions explain less of the variation in BMI (0.16-0.20%) than in European ancestry populations. 58 Results of targeted replication of FTO in Africans and African Americans have been inconsistent, 27,59-74 which might be due to the substantial differences in the LD between FTO SNPs in African compared with European or Asian ancestry populations ( Figure 1b ). As such, an FTO SNP that is part of the larger European-Asian cluster, but that does not overlap with the African cluster, will probably not show association with obesityrelated traits. However, in a largescale GWAS in populations of African ancestry, SNPs in FTO were among the most significantly associated with BMI (P = 10 -10 ), further establishing FTO as an obesity susceptibility locus in this ancestry. 26 While the effect of FTO on BMI in African populations was similar to that observed in those European ancestry, the minor allele frequency was much lower (12%; Figure 2 ), such that only 0.10% of the vari ation of BMI in those of African ancestry was explained (Table 1) . 26 SNPs in FTO are also associated with BMI and other obesityrelated traits in Hispanic and Latino populations [74] [75] [76] [77] and American Pima Indians. 78 Taken together, SNPs in FTO are associated with obesity related traits across many ancestries. However, the allele frequency of the BMIassociated FTO SNPs differs sub stantially across ancestries, with the highest prevalence of minor (risk) allele carriers observed in those with European ancestry, but substantially fewer in Asian and African populations (Figure 2 ). 
Box 1 | Linkage disequilibrium
Linkage disequilibrium (LD) measures the nonrandom association between alleles of different variants. LD is often expressed by the squared correlation co-efficient r 2 , which ranges between 0 and 1. The higher the r 2 , the closer the alleles are linked and the more likely they are to be inherited together. Any two alleles that are always inherited together, and are therefore closely linked, have an r 2 of 1. An allele inherited independently of another will have an r 2 of 0.
FTO and obesity risk over the life course
The association of FTO with obesityrelated traits has also been confirmed in studies of children and adoles cents. 8, [19] [20] [21] 38, 39, 56, [59] [60] [61] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] Although SNPs in FTO do not influence birth weight, [88] [89] [90] [91] [92] studies with multi ple meas ures over the life course show that FTO SNPs already affect body weight during early childhood (as early as 3 years old), after which the effect increases to reach its largest effect in young adulthood, followed by a subsequent weakening of the effect throughout adult hood. [86] [87] [88] [89] [90] 93, 94 Interestingly, a metaanalysis of eight BMI studies including children aged from 2 weeks to 13 years, showed that before 2.5 years, the BMIincreasing FTO allele was associated with reduced BMI. 94 This study further showed that individuals carrying the FTO allele associated with increased BMI in adults displayed an earlier childhood adiposity rebound, suggesting faster maturation, than those carrying other FTO alleles. 94 
FTO and lifestyle factors
To gain insight into the potential mechanisms through which variation in FTO leads to increased risk of obesity, many studies have examined whether SNPs in FTO are associated with food intake and physical activity, the two major mediators of body weight regulation.
Evidence supporting a role for FTO in the regula tion of food intake is increasing. The BMIincreasing allele of FTO is associated with increased energy, 80, [95] [96] [97] dietary fat 96, 98, 99 or protein intake, 97,100 increased appetite and reduced satiety, 101, 102 poor food choices and eating habits, 103, 104 and loss of control over eating. 105 A GWAS of macronutrient intake, in more than 70,000 indivi duals, found the BMIincreasing allele of FTO SNPs to be associ ated with increased protein intake (P = 10 -9 ), even after accounting for FTO's effect on BMI (P = 3 × 10 -7
). 106 Des pite this increasing evidence, some studies could not confirm the association of FTO with dietary traits. 43, 60, [107] [108] [109] [110] [111] Other studies have consistently shown that SNPs in FTO are not associated with levels of physical activ ity, 43, 100, [110] [111] [112] [113] [114] which has been convincingly confirmed in a largescale metaanalysis of published and unpublished data of 218,166 adults and 19,268 children. 115 Although physical activity does not seem to mediate the associa tion between FTO and obesity susceptibility, this meta analysis showed that the effect of FTO on BMI and obesity risk is approximately 30% lower in physically active than in sedentary adults. 115 These results confirm the obser vations of many individual studies 43, 73, [112] [113] [114] 116, 117 and emphasize the importance of physical activity in body weight regulation in adults-even those who are geneti cally susceptible to obesity benefit from being active. The mechanism that mediates the interaction between FTO and physical activity or other lifestyle factors, and whether this effect attenuation is observed only with physical activity or also with other lifestyle factors, is unclear. Some studies suggest that dietary habits, energy intake 97,100,108 and smoking 72 might also attenuate the effects of FTO on obesity susceptibility. SNPs in the first intron of FTO are associated with methy lation capability, and some investigators speculate that this region might be sensitive to epigenetic effects. [118] [119] [120] Studying lifestyle factors such as physical activity and food intake is challenging because their measurement can be inaccurate. Nevertheless, increasing evidence suggests that physical activity attenuates the association between FTO and obesity susceptibility, whereas food intake might mediate this association. However, which components of food intake are predominantly targeted by FTO still needs to be confirmed.
Obesity-related comorbidities
SNPs in the first intron of FTO associate with a number of adiposityrelated traits. Although there has been little support for a role of FTO in body fat distribu tion, assessed by waisttohip ratio adjusted for BMI, 121 a GWAS in >10,000 individuals with CT measures of adipose depots observed convincing association between FTO SNPs and subcutaneous (P = 6.2 × 10 -7 ), but not visceral (P = 0.17) adipose tissue. 122 Obesity is an important risk factor for cardiovascular and metabolic disease. Hence, it comes as no surprise that, because of the robust association between FTO and BMI, FTO SNPs are also associated with a range of cardiometabolic traits (Supplementary Table 1) . A largescale metaanalysis of 36 studies (n = 198,502) examined the effect of FTO on 24 cardiometabolic traits. In this study, the BMIincreasing allele of FTO was associated with increased risk of T2DM, heart failure, coronary heart disease, allcause and ischa emic stroke, hypertension, dyslipidaemia, metabolic syndrome and mortality, as well as with increased fasting glucose and insulin levels, 2 h oral glucose tolerance test glucose levels, HbA 1c , blood pressure, lipid levels, liver enzymes and inflammation markers (Supplementary Table 1) . 123 For most traits, these associations were medi ated by FTO's effect on BMI. 123 However, some evidence suggested that FTO might, at least in part, increase the risk of T2DM independently of its effect on BMI, 123 which is consistent with earlier observations. 57, 58, 124 Obesity is also considered a risk factor for certain cancers, which motivated researchers to also test if the BMIassociated FTO SNPs were associated with cancer. Whereas some studies found FTO SNPs to influence the risk of some cancers, [125] [126] [127] [128] [129] [130] [131] other studies could not confirm this. [132] [133] [134] [135] Interestingly, two largescale GWAS identified SNPs in the second and eighth intron of FTO that are robustly associated with risk of estrogen receptor negative breast cancer 136 and melanoma 137 (Supplementary Table 1 ). These two cancerassociated loci are independent (LD r 2 for European ancestry <0.10) from the BMIassociated locus in intron 1 of FTO and of each other. Their association with cancer risk is not mediated via an effect on BMI, 136, 137 indicating that FTO influences pathways other than those associated with body weight regulation.
FTO mutations and obesity risk
Three studies, have examined whether rare variants in FTO are disproportionally represented in obese or lean individuals. [138] [139] [140] At least 45 lowfrequency coding vari ants were identified, but no study found evidence of an enrichment of any particular variant, (individually or combined) in individuals with or without obesity, even though some are predicted to have deleterious effects on FTO function.
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FTO biology
FTO is a nucleic acid demethylase FTO is a 2oxyglutarate and Fe(II) dependent demethy lase, closely related to the bacterial DNA demethylase AlkB and the mammalian AlkB homologues, ABH1 and ABH2. 141 In vitro, recombinant FTO catalyses the Fe(II) dependent and 2oxyglutaratedependent demethyla tion of 3methylthymine in singlestranded DNA, 141, 142 and 3methyluracil 141, 142 and N6methyladenosine (known as m6a in short) 143 in RNA. This functionality suggests a potential role for FTO in nucleic acid repair The T-allele is the BMI-increasing allele. The 'ALL' group for each ancestry combines genotype frequencies from the different populations within the same ancestry.
or modification. The crystal structure of FTO shows an Nterminal catalytic domain and a Cterminal domain of unknown function. 144 The catalytic site contains five obligate amino acid residues found in all members of this enzyme superfamily: a histidine and an aspartic acid, required for binding Fe(II); and three residues, a histi dine and two arginines, separated by six amino acids, required for 2oxyglutarate binding. 138, 144 The specificity for singlestranded nucleic acids is provided by an L1 loop, not present in other members of the AlkB family, which prevents doublestranded nucleic acids from entering the catalytic pocket by steric hindrance. 144 FTO demethylates N6methyladenosine, the most common modified nucleoside in mRNA, 145 with 50fold greater affinity than 3methyluracil, 143 which is found largely in ribosomal RNA. 146 However, because the vast majority of total RNA is ribosomal RNA there is, in absolute terms, far more 3methyluracil than N6methyladenosine in any given cell (Loos and Yeo, unpublished observations). Whether one or both of these modified bases are the endogenous substrate for FTO is still not clear.
FTO deficiency
Multiple examples exist where common variants close to a particular gene, such as MCR4, 11, [147] [148] [149] 153, 154 are associated with altera tions in risk of common phenotypes, such as increased fat mass and obesity. Rare lossoffunction mutations in these same genes can lead to a highly penetrant severe earlyonset obesity. However, FTO is more complicated. Fto was originally identified as one of six contiguous genes in a 1.6 Mb chromosomal deletion causing the fusedtoe phenotype in mice. 155 This deletion included Ftm, Ftl, the iroquois B cluster (consisting of Irx3, Irx5, and Irx6), as well as Fto. Mice homozygous for the del etion are embryonically lethal, whereas heterozygous fusedtoe mutants have severe developmental abnor malities including defective left-right asymmetry, 156 impaired hypothalamic development, 156, 157 as well as fused digits and hyperplasia of the thymus without any metabolic alterations. By contrast, mice with a specific targeted deletion of Fto did not display such severe develop mental abnormalities, but had retarded post natal growth, decreased fat and lean body mass, and elevated food intake when corrected for lean body mass. 158 Postnatal lethality is also high, with only 50% of homozygous pups reaching weaning age. 158, 159 In humans, a lossoffunction FTO mutation leads to a complex phenotype of postnatal growth retarda tion, microcephaly, severe psychomotor delay, func tional brain deficits and facial dysmorphism. 160 In some patients, structural brain malformations, cardiac defects, genital anomalies and cleft palate are also seen. The Arg316Gln mutation, which swaps an arginine neces sary for 2 oxyglutarate binding for a glutamine, leads to a loss of FTO demethylase activity. The importance of FTO's ability to demethylate is underlined by the severe phenotype; moreover, no affected individual has survived past the age of 30 months. 160 In both humans and mice, therefore, a fully functional FTO is critical for normal physiology.
The role of RPGRIP1L SNPs in FTO associated with the highest risk of obesity are close to the transcriptional start site of RPGRIP1L, the human orthologue of mouse Ftm, which is adja cent to FTO but coded for on the opposite DNA strand (Figure 1a) . 28 Initial studies focused on FTO because it is nutritionally regulated in the hypothalamus, 141 whereas RPGRIP1L localizes in the primary cilia and centrosomes of ciliated cells. 161 Mutations in the RPGRIP1L gene lead to Joubert syndrome type 7, which presents with cerebel lar and brainstem malformation and renal failure. 161 Patients with Joubert syndrome type 7 have no obvious bodyweightrelated phenotypes. However, a 'lean' pheno type is difficult to identify in a healthy individual, let alone a patient who is severely ill. In mice, deletion of Ftm recapitulates the cerebral, renal and hepatic defects seen in patients with Joubert s yndrome type 7. 161 Some evidence suggests that FTO and RPGRIP1L are coregulated. A region in intron 1 of FTO contains at least two putative cutlike homeobox 1 transcription factor binding sites, one of which overlaps with other obesityassociated SNPs.
27,28 Furthermore, in vitro evidence indicates that FTO can function as a tran scriptional coactivator of CCAAT/enhancerbinding proteins. 162 The association between FTO and body weight regulation might, therefore, be mediated through expression changes in both FTO and RPGRIP1L, but this hypothesis has yet to be proved.
FTO expression and energy homeostasis
Despite the severe phenotype seen in FTO deficiency, there is evidence that FTO might regulate energy homeo stasis. For example, mice with a knockout of the Fto gene (Fto -/-) have an apparent hyperphagia, and Fto +/-mice are resistant to obesity induced by a highfat diet.
158 A knockin mouse model, which expresses additional copies of Fto, shows that ubiquitous Fto over expression leads to a dosedependent increase in body and fat mass, irrespective of whether mice are fed a stand ard or a high fat diet. 163 However, although this weight increase cor relates with the lean phenotype of FTO deficiency, the increased food intake seen in these mice does not. Obese mice with increased fat mass would be expected to have increased leptin levels, but at 8 weeks, mice overexpress ing Fto have reduced fasting leptin levels. 163 The hyper phagic phenotype might, therefore, plausibly be driven by hypoleptinaemia in these Fto mutant mice.
FTO is expressed ubiquitously in human and animal tissues, 141 which is consistent with the observation that multiple organ systems are affected by FTO deficiency. FTO expression is highest in the brain, including the hypothalamus, a region with a key role in the control of food intake. 141 Within the arcuate nucleus of the hypo thalamus, nutritional status regulates FTO expression, which decreases following a 48 h fast 141 and increases after a 10week exposure to a highfat diet. Moreover, modulating FTO levels specifically in the arcuate nucleus can influence food intake. 164 Despite inconsistencies between different mouse models, FTO seems to influence energy homeostasis by directly regulating food intake. Surprisingly, mouse lines, in which Fto has been specifically deleted in the brain recapitulate much of the phenotype of the whole body knockouts, 165 suggesting that a substantial propor tion of FTO function, particularly in regulating energy h omeostasis, is mediated by the brain.
FTO as a nutrient sensor
Given that FTO is nutritionally regulated and can influ ence food intake, a role for FTO as a nutrient sensor is possible. With 2oxyglutarate being a cosubstrate of FTO and a key intermediate in the citricacid cycle, initial studies explored whether FTO senses intracellu lar concentrations of this metabolite. However, typical intracellular concentrations of 2oxyglutarate are more than 10fold higher than its calculated dissociation con stant (K m ) of 2.88 μM, so a physiological role for FTO in sensing 2oxyglutarate seems unlikely. 166 However, FTO mRNA and protein levels are dramati cally downregulated by amino acid deprivation in mouse and human cell lines. 167 Strikingly, this regulation was seen only with essential amino acids. 167 Overall these results suggest that amino acids regulate FTO expres sion, which can lead to a growth retardation phenotype during FTO deficiency.
FTO and mTORC1 signalling
Mouse embryonic fibroblasts (MEFs) derived from Fto -/-mutants have slower rates of growth and reduced mRNA translation than wildtype MEFs, 168 which might result from maintenance of aminoacyltRNA synthetase levels, as part of a multimer known as the multisynthetase complex (MSC). 169 The MSC tethers free amino acids to their cognate tRNAs and is a key modulator of transla tion. Consistent with reduced rates of translation, MEFs derived from Fto -/-mice have reduced levels of MSC components. In Fto -/--derived MEFs, mRNA transla tion and MSC levels are rescued by transfection with wild type FTO, implying that FTO can regulate translation by maintaining the MSC. 168 In addition, cells lacking FTO have decreased activa tion of the mammalian target of rapamycin complex 1 (mTORC1) pathway, a key regulator of cell growth, mRNA translation and autophagy, the basic catabolic mechanism that involves cell degradation of unnecessary or dysfunctional cellular components via the lysosomal machinery. These cellular responses might explain the growth retard ation seen in Fto -/-mice 158 and in humans with a homozygous lossoffunction FTO mutation. 160 The regulation of FTO by amino acids 167 seems to be neces sary for the cellular response to changing amino acid levels. Expression of exogenous FTO renders cells insensitive to aminoacid deprivation by preventing the expected reduction in mTORC1 signalling. 168 A cell that lacks FTO cannot sense amino acids, thus responds by reducing mTORC1 signalling and increasing autophagy to maintain cellular energy levels and ensure survival (Figure 3 ). For example, wholebody deletion of Fto in adult mice led to a loss of weight, particularly in lean body mass. 159 Skeletal muscle is the largest mass of protein in the body and potentially the most sensi tive to the sudden global FTO removal and subsequent increase in autophagy. By contrast, when FTO is post natally deleted, specifically in the mediobasal hypothala mus, a more subtle weight loss occurs, due to a change in food intake. 159 
FTO and N6-methyladenosine
The link between aminoacid availability and mTORC1 signalling is dependent on FTO demethylase activ ity, although the how and why remain unclear. 168 One possibility could involve FTO's ability to demethy late N6methyladenosine. Using antibodies against N6methyladenosine to immunoprecipitate human and b | In conditions of amino-acid deprivation, FTO levels drop, leading to decreased mTORC1 activity, mRNA translation and cell growth, whereas autophagy is increased. This mechanism ensures cellular survival by maintaining cellular energy levels. c | A cell with defective FTO (red X) interprets this as amino-acid starvation, thereby reducing mTORC1 signalling and increasing autophagy. Abbreviations: AA, amino acid; FTO, fat mass and obesity associated gene; mTORC1, mammalian target of rapamycin complex 1.
mouse RNA transcripts that carry the nucleotide modifi cation, two studies have mapped N6methyladenosine in a transcriptomewide manner. 170, 171 N6methyladenosines are common, enriched near stopcodons, highly con served between mice and humans, and are dynamically, develop mentally and tissuespecifically regulated. 170, 171 The presence of N6methyladenosine at appropriate mRNA sites seems to have a fundamental role in regulat ing gene expression, in addition to exerting varying effects on mRNA splicing and transport. 170, 171 Methyltransferase like 3 is currently the only enzyme identified that methy lates adenosine to the N6methyladenosine form, 172 wheres two enzymes are known to catalyse the removal of this methyl group: ALKBH5 173 and FTO. 143 In fact, transient overexpression of FTO in HEK293 cells decreases the total amount of N6methyladenosine in the transcriptome. 171 However, FTO does not globally target all N6 methyladenosinemodified mRNAs but demethy lates only a specific subset. 174 The midbrain and striatum in Fto -/-mice have increased methylation in mRNAs encod ing components of the dopamine signalling pathway, consequently dopaminergic signalling is reduced. 174 Dopa minergic signalling is crucial for the regulation of learning, reward behaviour and feeding. Outside the brain, FTO risk alleles can influence the methylation of ghrelin mRNA, which might affect levels of the circu lating protein. 175 Ghrelin is a powerful orexigenic signal produced by the stomach, whose circulating levels nor mally peak before the onset of a meal. Further studies should determine the extent to which changes in dopa mine and/or ghrelin signalling could be effectors of FTO's association with increased BMI. 175 
Conclusions
How does the biochemical function of FTO relate to the association between FTO SNPs and obesity? In truth, we still do not know. Little is known about if or how the FTO risk alleles influence the FTO protein.
Considering their intronic location, SNPs are unlikely to cause functional mutations, but might regulate FTO transcription in a more subtle way, either by upregulating or d ownregulating FTO expression.
FTO is most highly expressed in the brain, where amino acids can influence the activity of pathways control ling food intake. We hypothesize that subtle effects of the risk alleles on FTO expression in regions of the brain, such as the hypothalamus, might influence how these cells sense aminoacid levels. Human carriers of the susceptible SNPs in FTO not only consume more food but also have altered nutrient preference, suggest ing that FTO status influences the sensing of dietary macronutrient composition. The role of FTO in amino acid sensing might aid our understanding of the cellular basis of this physiological phenomenon.
Considering that a substantial proportion of the world's population have their body weight subtly influenced by SNPs in FTO, can FTO ever be considered a realistic pharmaceutical target? Given the ubiquitous expression of FTO, the severe phenotype in humans and mice with FTO deficiency, and that adult FTO del etion leads to a dramatic loss of muscle mass, we do not believe FTO is a good target for future drugs. However, understanding the biology underpinning FTO function might reveal novel therapeutic targets to treat obesity. Furthermore, using the statistical association of FTO and BMI to under stand the underlying biology can serve as a template for future GWAS of obesity genes with unknown function.
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